Stem cell transplant tracking study
Part of Blood & lymphatic clinical trials.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had at least one visit to a stem cell transplant center starting from January 1, 2021
- You are scheduled for or have already received a stem cell transplant
- You do not have any other serious medical conditions that would prevent long-term follow-up
- You do not have alcohol or drug problems that would affect your ability to follow the study rules
- You do not have any other condition that the doctor thinks could make the study unsafe or hard for you to complete
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood sugar problems in people who have had a stem cell transplant from a donor. It may help doctors learn how to better manage or prevent diabetes after a transplant.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
This study creates a record of people who are eligible to receive a stem cell (blood-forming cell) transplant. It helps researchers learn about transplant patients and outcomes over time.
This study aims to collect, store, and share data from patients who are receiving standard intensive treatment and a stem cell transplant from either their own cells or a donor. It may help improve how future patients are treated by building a reliable record of outcomes and care patterns.
This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.